<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>respiratory medicine</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>respiratory medicine | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C)
Authors: Iqbal, K.; Sinha, S.; David, P.; De Marco, G.; Taheri, S.; McLaren, E.; MAISURIA, S.; ARUMUGAKANI, G.; Ash, Z.; BUCKLEY, C.; COLES, L.; HETTIARACHCHI, C.; SMITHSON, G.; SLADE, M.; Shah, R.; MARZO-ORTEGA, H.; Keen, M.; Lawson, C.; McLorinan, J.; NIZAM, S.; Reddy, H.; Sharif, O.; Sultan, S.; Tran, G.; WOOD, M.; WOOD, S.; Ghosh, P.; McGonagle, D.
Score: 7.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/respiratory-medicine/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="respiratory medicine" />
<meta property="og:description" content="MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C)
Authors: Iqbal, K.; Sinha, S.; David, P.; De Marco, G.; Taheri, S.; McLaren, E.; MAISURIA, S.; ARUMUGAKANI, G.; Ash, Z.; BUCKLEY, C.; COLES, L.; HETTIARACHCHI, C.; SMITHSON, G.; SLADE, M.; Shah, R.; MARZO-ORTEGA, H.; Keen, M.; Lawson, C.; McLorinan, J.; NIZAM, S.; Reddy, H.; Sharif, O.; Sultan, S.; Tran, G.; WOOD, M.; WOOD, S.; Ghosh, P.; McGonagle, D.
Score: 7." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/respiratory-medicine/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-11-08T10:39:23+00:00" />
<meta property="article:modified_time" content="2023-11-08T10:39:23+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="respiratory medicine"/>
<meta name="twitter:description" content="MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C)
Authors: Iqbal, K.; Sinha, S.; David, P.; De Marco, G.; Taheri, S.; McLaren, E.; MAISURIA, S.; ARUMUGAKANI, G.; Ash, Z.; BUCKLEY, C.; COLES, L.; HETTIARACHCHI, C.; SMITHSON, G.; SLADE, M.; Shah, R.; MARZO-ORTEGA, H.; Keen, M.; Lawson, C.; McLorinan, J.; NIZAM, S.; Reddy, H.; Sharif, O.; Sultan, S.; Tran, G.; WOOD, M.; WOOD, S.; Ghosh, P.; McGonagle, D.
Score: 7."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "respiratory medicine",
      "item": "https://trxiv.yorks0n.com/posts/respiratory-medicine/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "respiratory medicine",
  "name": "respiratory medicine",
  "description": "MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C)\nAuthors: Iqbal, K.; Sinha, S.; David, P.; De Marco, G.; Taheri, S.; McLaren, E.; MAISURIA, S.; ARUMUGAKANI, G.; Ash, Z.; BUCKLEY, C.; COLES, L.; HETTIARACHCHI, C.; SMITHSON, G.; SLADE, M.; Shah, R.; MARZO-ORTEGA, H.; Keen, M.; Lawson, C.; McLorinan, J.; NIZAM, S.; Reddy, H.; Sharif, O.; Sultan, S.; Tran, G.; WOOD, M.; WOOD, S.; Ghosh, P.; McGonagle, D.\nScore: 7.",
  "keywords": [
    
  ],
  "articleBody": " MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C)\nAuthors: Iqbal, K.; Sinha, S.; David, P.; De Marco, G.; Taheri, S.; McLaren, E.; MAISURIA, S.; ARUMUGAKANI, G.; Ash, Z.; BUCKLEY, C.; COLES, L.; HETTIARACHCHI, C.; SMITHSON, G.; SLADE, M.; Shah, R.; MARZO-ORTEGA, H.; Keen, M.; Lawson, C.; McLorinan, J.; NIZAM, S.; Reddy, H.; Sharif, O.; Sultan, S.; Tran, G.; WOOD, M.; WOOD, S.; Ghosh, P.; McGonagle, D.\nScore: 7.3, Published: 2023-11-05 DOI: 10.1101/2023.11.03.23297727\nBackground: Anti-MDA5 (Melanoma differentiation-associated protein-5) positive dermatomyositis (MDA5+-DM) is characterised by rapidly progressive interstitial lung disease (ILD) and high mortality. MDA5 senses single-stranded RNA and is a key pattern recognition receptor for the SARS-CoV-2 virus. Methods: This is a retrospective observational study of a surge in MDA5 autoimmunity, as determined using a 15 muscle-specific autoantibodies (MSAs) panel, between Janurary 2018-December 2022 in Yorkshire, UK. MDA5-positivity was correlated with clinical features and outcome, and regional SARS-CoV-2 positivity and vaccination rates. Gene expression patterns in COVID-19 were compared with autoimmune lung disease and idiopathic pulmonary fibrosis (IPF) to gain clues into the genesis of the observed MDA5+-DM outbreak. Results: Sixty new anti-MDA5+, but not other MSAs surged between 2020-2022, increasing from 0.4% in 2019 to 2.1% (2020), 4.8% (2021) and 1.7% (2022). Few (8/60) had a prior history of confirmed COVID-19, peak rates overlapped with regional SARS-COV-2 community positivity rates in 2021, and 58% (35/60) had received anti-SARS-CoV-2 RNA vaccines. Few (8/60) had a prior history of COVID-19, whereas 58% (35/60) had received anti-SARS-CoV-2 RNA vaccines. 25/60 cases developed ILD which rapidly progression with death in 8 cases. Among the 35/60 non-ILD cases, 14 had myositis, 17 Raynaud phenomena and 10 had dermatomyositis spectrum rashes. Transcriptomic studies showed strong IFIH1 (gene encoding for MDA5) induction in COVID-19 and autoimmune-ILD, but not IPF, and IFIH1 strongly correlated with an IL-15-centric type-1 interferon response and an activated CD8+ T cell signature that is an immunologic hallmark of progressive ILD in the setting of systemic autoimmune rheumatic diseases. The IFIH1 rs1990760TT variant blunted such response. Conclusions: A distinct pattern of MDA5-autoimmunity cases surged contemporaneously with circulation of the SARS-COV-2 virus during COVID-19. Bioinformatic insights suggest a shared immunopathology with known autoimmune lung disease mechanisms.\n",
  "wordCount" : "363",
  "inLanguage": "en",
  "datePublished": "2023-11-08T10:39:23Z",
  "dateModified": "2023-11-08T10:39:23Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/respiratory-medicine/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      respiratory medicine
    </h1>
    <div class="post-meta">&lt;span&gt;updated on November 8, 2023&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.11.03.23297727">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.11.03.23297727" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.11.03.23297727">
        <p class="paperTitle">MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C)</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.11.03.23297727" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.11.03.23297727" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Iqbal, K.; Sinha, S.; David, P.; De Marco, G.; Taheri, S.; McLaren, E.; MAISURIA, S.; ARUMUGAKANI, G.; Ash, Z.; BUCKLEY, C.; COLES, L.; HETTIARACHCHI, C.; SMITHSON, G.; SLADE, M.; Shah, R.; MARZO-ORTEGA, H.; Keen, M.; Lawson, C.; McLorinan, J.; NIZAM, S.; Reddy, H.; Sharif, O.; Sultan, S.; Tran, G.; WOOD, M.; WOOD, S.; Ghosh, P.; McGonagle, D.</p>
        <p class="info">Score: 7.3, Published: 2023-11-05 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.11.03.23297727' target='https://doi.org/10.1101/2023.11.03.23297727'> 10.1101/2023.11.03.23297727</a></p>
        <p class="abstract">Background: Anti-MDA5 (Melanoma differentiation-associated protein-5) positive dermatomyositis (MDA5&#43;-DM) is characterised by rapidly progressive interstitial lung disease (ILD) and high mortality. MDA5 senses single-stranded RNA and is a key pattern recognition receptor for the SARS-CoV-2 virus. Methods: This is a retrospective observational study of a surge in MDA5 autoimmunity, as determined using a 15 muscle-specific autoantibodies (MSAs) panel, between Janurary 2018-December 2022 in Yorkshire, UK. MDA5-positivity was correlated with clinical features and outcome, and regional SARS-CoV-2 positivity and vaccination rates. Gene expression patterns in COVID-19 were compared with autoimmune lung disease and idiopathic pulmonary fibrosis (IPF) to gain clues into the genesis of the observed MDA5&#43;-DM outbreak. Results: Sixty new anti-MDA5&#43;, but not other MSAs surged between 2020-2022, increasing from 0.4% in 2019 to 2.1% (2020), 4.8% (2021) and 1.7% (2022). Few (8/60) had a prior history of confirmed COVID-19, peak rates overlapped with regional SARS-COV-2 community positivity rates in 2021, and 58% (35/60) had received anti-SARS-CoV-2 RNA vaccines. Few (8/60) had a prior history of COVID-19, whereas 58% (35/60) had received anti-SARS-CoV-2 RNA vaccines. 25/60 cases developed ILD which rapidly progression with death in 8 cases. Among the 35/60 non-ILD cases, 14 had myositis, 17 Raynaud phenomena and 10 had dermatomyositis spectrum rashes. Transcriptomic studies showed strong IFIH1 (gene encoding for MDA5) induction in COVID-19 and autoimmune-ILD, but not IPF, and IFIH1 strongly correlated with an IL-15-centric type-1 interferon response and an activated CD8&#43; T cell signature that is an immunologic hallmark of progressive ILD in the setting of systemic autoimmune rheumatic diseases. The IFIH1 rs1990760TT variant blunted such response. Conclusions: A distinct pattern of MDA5-autoimmunity cases surged contemporaneously with circulation of the SARS-COV-2 virus during COVID-19. Bioinformatic insights suggest a shared immunopathology with known autoimmune lung disease mechanisms.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
